Loading...

Automation And Industry 40 Will Empower Aerospace, Defense, Medical Sectors

Published
06 May 25
Updated
06 Mar 26
Views
76
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-23.5%
7D
4.3%

Author's Valuation

₹426.7826.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 06 Mar 26

CYIENTDLM: Upcoming Board And Shareholder Decisions Will Support Upside Potential

Analysts have kept their fair value estimate for Cyient DLM steady at ₹426.78, citing only marginal tweaks to inputs such as the discount rate, revenue growth, profit margin and assumed future P/E. These adjustments do not materially shift their overall view on the stock.

What's in the News

  • A board meeting is scheduled for Jan 20, 2026, to consider and approve the unaudited financial results for the quarter ended Dec 31, 2025; review a proposed variation in the objects of IPO funds, subject to shareholder approval via postal ballot; and approve the reconstitution of Board committees (Key Developments).
  • A special or extraordinary shareholders meeting will be held on Jan 11, 2026, via postal ballot in India, to vote on appointing Dr. Ganesh Natarajan as a non-executive, independent director; reappointing Dr. Vanitha Datla and Mr. Jehangir Ardeshir as non-executive, independent directors for second terms; and appointing Mr. Giridhar Aramane as a non-executive, independent director (Key Developments).
  • A special or extraordinary shareholders meeting is scheduled for Mar 08, 2026, via postal ballot in India, with details indicating that shareholder decisions will be taken through remote voting rather than an in-person meeting (Key Developments).

Valuation Changes

  • Fair Value: Kept unchanged at ₹426.78 per share, indicating no shift in the overall valuation outcome.
  • Discount Rate: Trimmed slightly from 14.95% to 14.93%, a very small adjustment to the required return assumption.
  • Revenue Growth: Held effectively steady at 21.00%, with only an immaterial rounding change in the model input.
  • Net Profit Margin: Maintained at about 7.32%, with the updated figure showing only a tiny refinement to the prior estimate.
  • Future P/E: Eased marginally from 29.54x to 29.52x, reflecting a minor tweak to the long term valuation multiple used.
1 viewusers have viewed this narrative update

Key Takeaways

  • Strong order intake from high-reliability sectors and supply chain shifts is driving revenue acceleration and greater earnings visibility in the near and medium term.
  • Higher-margin business, automation investments, and expanding manufacturing footprint signal structural margin improvement and diversified, higher-quality earnings growth.
  • Heavy reliance on a narrow customer base, supply chain vulnerabilities, acquisition integration challenges, and industry competition may constrain sustainable revenue growth and margin expansion.

Catalysts

About Cyient DLM
    Provides electronic manufacturing solutions in India and internationally.
What are the underlying business or industry changes driving this perspective?
  • The accelerating global shift towards automation, digitalization, and Industry 4.0 is boosting RFQs from both existing and new clients in high-reliability sectors (aerospace, defense, medical, and industrial), which, combined with supply chain diversification strategies like "China + 1", is driving strong order intake, indicating likely revenue acceleration and improved visibility over the next several quarters.
  • Cyient DLM's book-to-bill ratio has reached its highest level in 8–10 quarters, with nearly 50% of recent orders executable within the current year and a healthy order backlog mix; this positions the company for near-term revenue growth and provides a robust foundation for longer-term earnings predictability.
  • The current order backlog features a significantly higher share of higher-margin business, supported by ongoing investments in factory automation and process digitization, suggesting a structural improvement in EBITDA margins and sustainable margin expansion as revenue recovers.
  • Expansion of the company's manufacturing footprint (leveraging both India's cost advantages and on-shore U.S. capacity), along with execution of its build-to-spec offerings and new client wins (e.g., Deutsche Aircraft, U.S. defense), is set to drive revenue diversification and enable higher-value project wins, supporting both topline and earnings quality.
  • Low current capacity utilization (~55–60%) and a cost base built for larger scale create substantial operating leverage; as new, higher-quality orders ramp up and legacy orders phase out, earnings growth is likely to outpace revenue growth, supporting medium-term margin expansion and increased return on capital.

Cyient DLM Earnings and Revenue Growth

Cyient DLM Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Cyient DLM's revenue will grow by 20.2% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.2% today to 7.2% in 3 years time.
  • Analysts expect earnings to reach ₹1.9 billion (and earnings per share of ₹20.58) by about September 2028, up from ₹649.4 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 32.2x on those 2028 earnings, down from 53.8x today. This future PE is lower than the current PE for the IN Electronic industry at 43.9x.
  • Analysts expect the number of shares outstanding to grow by 0.18% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 15.13%, as per the Simply Wall St company report.

Cyient DLM Future Earnings Per Share Growth

Cyient DLM Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Heavy dependence on a limited set of large defense and aerospace customers (e.g., BEL repeat order) exposes Cyient DLM to revenue volatility; delays or non-renewals in these lumpy orders can lead to unpredictable topline growth.
  • Short to medium-term supply chain disruptions due to geopolitical events (such as the Middle East conflict) highlight ongoing exposure to global trade friction and logistic bottlenecks, which can increase input costs and impact delivery timelines-potentially compressing margins and disrupting revenue recognition.
  • Ongoing integration of acquisitions (like Altek) may carry execution and synergy risks, especially given different cost structures and the challenge of maintaining profitability across geographies-affecting sustainable EBITDA and earnings growth.
  • Pivot towards new industries and build-to-spec (B2S) offerings requires successful technology and product development; failure to move up the value chain or diversify beyond legacy low-margin businesses may limit improvements in both revenue quality and net margins.
  • The sector faces secular risks from intensifying global EMS competition and rapid technological obsolescence; these trends could lead to industry-wide commoditization, suppressing pricing power and pressuring both long-term revenue and sustainable margin expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of ₹516.625 for Cyient DLM based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹600.0, and the most bearish reporting a price target of just ₹450.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ₹26.7 billion, earnings will come to ₹1.9 billion, and it would be trading on a PE ratio of 32.2x, assuming you use a discount rate of 15.1%.
  • Given the current share price of ₹439.85, the analyst price target of ₹516.62 is 14.9% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Cyient DLM?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives